acute severe pain
Pain · 2019–2019
2decisions
2medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the 2 made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| oxycodone Acute severe disabling pain unresponsive to non-opioid analgesics for short-term use (2–3 days) in patients with severe disabling pain. | Jul 2019 | Recommended with restriction | none received |
| oxycodone, tramadol, codeine, hydromorphone, morphine, tapentadol, buprenorphine, fentanyl Short-term relief of acute severe pain unresponsive to non-opioid analgesics; management of chronic severe pain in cancer and palliative care settings. | Dec 2019 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 2 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.